Safety and Efficacy of Remote Ischemic Conditioning in Patients With Spontaneous Intracerebral Hemorrhage

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorYi Yang

About this trial

The purpose of this study is to determine whether treatment with remote ischemic conditioning is of sufficient promise to improve outcome before conducting a larger clinical trial to examine its effectiveness as a treatment for intracerebral hemorrhage.

Eligibility criteria

Qualifiers

Age ≥ 18 years

Supratentorial intracerebral hemorrhage confirmed by brain CT scan

Functional independence prior to ICH, defined as pre-ICH mRS ≤ 1

NIHSS score ≥ 4 and GCS ≥ 6 upon presentation

Disqualifiers

Definite evidence of secondary ICH, such as structural abnormality, brain tumor, thrombolytic drug, and other causes

A very high likelihood that the patient will die within the next 24 hours on the basis of clinical and/or radiological criteria

Already booked for surgical treatment

Life expectancy of less than 90 days due to comorbid conditions

Trial design

Treatments tested in this trial

  • Remote ischemic conditioning
  • Sham remote ischemic conditioning

Treatment groups

530 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Yi Yang

Lead sponsor

The First Hospital of Jilin University

Sponsor institution